Molecular mimicry between parasites and cancer: a novel approach for developing cancer vaccines and therapeutic

Maha Mohamed Eissa1, Sonia Rifaat Ahmed Allam1, Cherine Adel Ismail2

  • 1Department of Medical Parasitology, Faculty of Medicine, Alexandria University, Al-Moassat Medical Campus, Alexandria, Egypt.

Insights

This study explored molecular mimicry between parasites and cancer cells, finding shared antigens between Trichinella spiralis and Schistosoma mansoni with breast and lung cancer cells. This discovery could lead to new parasite-derived cancer immunotherapies.

Area of Science:

  • Immunology
  • Parasitology
  • Oncology

Background:

  • Conventional cancer treatments have limitations and side effects.
  • Cancer immunotherapy and targeted therapies are emerging as promising alternatives.
  • Parasite-based cancer therapy, particularly leveraging molecular mimicry, shows potential for novel anti-cancer strategies.

Purpose of the Study:

  • To investigate shared antigenic proteins between specific parasites (Trichinella spiralis, Schistosoma mansoni, Toxoplasma gondii) and human cancer cell lines (MCF-7, A549).
  • To explore the molecular mimicry theory as a basis for parasite-mediated anti-cancer effects.

Main Methods:

  • Generation of polyclonal antisera against T. spiralis, S. mansoni, and T. gondii in rabbits.
  • Detection of antibody reactivity with cancer cell extracts using SDS-PAGE and immunoblotting.
  • Analysis of cross-reactivity to identify shared antigens between parasites and cancer cells.

Main Results:

  • Cross-reactive bands were observed between T. spiralis antibodies and both MCF-7 and A549 cancer cell extracts (approx. 70 and 35 kDa).
  • Cross-reactivity was also found between S. mansoni antibodies and cancer cell extracts (approx. 80 kDa).
  • T. gondii antibodies did not show reactivity with the tested cancer cell lines.

Conclusions:

  • The study provides evidence for molecular mimicry between T. spiralis and S. mansoni parasites and human breast and lung cancer cells.
  • These findings lay the groundwork for further research into parasite-cancer antigen interactions.
  • Identification of these cross-reactive antigens could pave the way for developing novel cancer vaccines and therapeutic antibodies derived from parasites.

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
347
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
476